Clinical Trial Update: Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

View source ↗

Summary

A clinical trial is recruiting to evaluate how bone metastases in non-small cell lung cancer with actionable driver mutations respond to tyrosine kinase inhibit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tyrosine kinase inhibitors

Snippet

Sponsor: University of Colorado, Denver | Conditions: Carcinoma, Non-Small-Cell Lung | Status: RECRUITING